Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet
If you notice tasks like carrying groceries or climbing stairs becoming harder despite weight loss, it could signal muscle loss
No licensed Australian doctor can legally prescribe it through standard channels
This is in partial contrast to a study that found an increase in PSD95 in the hippocampus of male mice after GLP-1 receptor agonist treatment (99) in 5XFAD mice (a mouse model of Alzheimers disease), but not young, male wild-type young male mice
GLP-1 infusion slows gastric emptying of solid and liquid components of food and alters the distribution of food in the stomach so that a greater proportion of food is retained in the distal stomach (Marathe et al., 2011)
At Regency Medical Spa & Hair Clinic, our experienced medical team provides comprehensive evaluations to determine if semaglutide G LP-1 is right for you